United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Sector average (own scale)
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.
Want the full financial forecast report for TuHURA Biosciences, Inc./NV? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -221.51% | -652.38% | 145.75% | 90.89% | 76.56% | 71.87% |
| Sector average | 22.99% | 73.17% | 65.88% | 68.36% | 41.61% | 44.34% |
| ROA | -179.12% | -125.44% | -251.51% | -497% | -986.64% | - |
| Total Assets | $27,353.16K | $23,733.21K | $23,733.21K | $23,733.21K | $23,733.21K | $23,733.21K |
| Sector average | $3,516,665.42K | $3,537,396.33K | $3,954,880.66K | |||
| Net Income | -$30,051.98K | -$32,041.69K | -$59,691.42K | -$117,955.17K | -$234,160.52K | -$474,389.82K |
| Valuation | $48,241.05K | $51,435.04K | $95,819.87K | $189,347.97K | $375,887.03K | $751,774.07K |
| Sector average | $108,901,205.39K | $221,258,895.17K | $10,256,554.58K | |||
| Stock Price | $0.76 | $0.81 | $1.50 | $2.97 | $5.90 | $11.80 |
| $4,602,556.36K |
| $5,424,035.31K |
| $6,260,073.84K |
| $8,537,157.01K |
| $13,070,508.86K |
| $21,933,198.76K |